Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin glue spray to prevent delayed bleeding after gastric endoscopic submucosal dissection
ChiCTR1900025406Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tachosil in gastric cancer (GC), gastric adenoma and gastric preneoplasia (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Rate of delayed bleeding after surgery. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
tachosil
03
Conditions
gastric cancer (GC)gastric adenomagastric preneoplasia
Beyond the preview
Go deeper on ChiCTR1900025406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025406.